Cyclacel Pharmaceuticals' Series D Round

Cyclacel Pharmaceuticals raised a round of funding on January 10, 2004.

Cyclacel Pharmaceuticals is a biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.…

Articles about Cyclacel Pharmaceuticals' Series D Round: